CORC

浏览/检索结果: 共37条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors 期刊论文
2019, 卷号: 181, 页码: 111552
作者:  Wei Huiqiang;  Duan Yuqing;  Gou Wenfeng;  Cui Jie;  Ning Hongxin
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling 期刊论文
2019, 卷号: 16, 期号: 3, 页码: 606-617
作者:  Ma Li;  She Chunhua;  Shi Qian;  Yin Qiang;  Ji Xinxin
收藏  |  浏览/下载:25/0  |  提交时间:2020/01/03
Corrigendum to "A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study" [J. Pharm 期刊论文
2019
作者:  Yao Xueting;  Song Ling;  Liu Yang;  Wang Huanhuan;  Liu Jie
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer 期刊论文
2019, 卷号: 11, 期号: 5, 页码: 1779-+
作者:  Liu, Yu-Tao;  Han, Xiao-Hong;  Xing, Pu-Yuan;  Hu, King-Sheng;  Hao, Xue-Zhi
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
A novel PI3K/mTOR dual inhibitor XH002 exhibited robust antitumor activity in NSCLC 期刊论文
2019, 卷号: 27, 期号: 4, 页码: 451-459
作者:  Lv, Yuanhao;  Du, Tingting;  Ji, Ming;  Wang, Chunyang;  Lin, Songwen
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
XH002  PI3K  mTOR  NSCLC  EGFR  T790M  
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial 期刊论文
2019, 卷号: 11, 页码: 4449-4459
作者:  Hu, Xing-Sheng;  Han, Xiao-Hong;  Yang, Sheng;  Li, Ning;  Wang, Lin
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial 期刊论文
2019, 卷号: 37, 期号: 4, 页码: 731-737
作者:  Duan, Jian-Chun;  Wang, Zhi-Jie;  Lin, Lin;  Li, Jun-Ling;  Wang, Yan
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study 期刊论文
2019, 卷号: 166, 页码: 20-29
作者:  Yao, Xueting;  Song, Ling;  Liu, Yang;  Wang, Huanhuan;  Liu, Jie
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study 期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1461-1469
作者:  Cheng, Ying;  Wang, Yan;  Zhao, Jun;  Liu, Yunpeng;  Gao, Hongjun
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Comparison of up-front radiotherapy and TKI with TKI alone for NSCLC with brain metastases and EGFR mutation: A meta-analysis 期刊论文
2018, 卷号: 122, 页码: 94-99
作者:  Wang, Chunyu;  Lu, Xiaotong;  Lyu, Zhangyan;  Bi, Nan;  Wang, Luhua
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace